pmid,title,journal,year,drug,disease
39377297,Selected Acute Safety Events Following the Use of Nirmatrelvir/Ritonavir or Molnupiravir for COVID-19: A Nationwide Cohort Study in South Korea.,Clinical pharmacology and therapeutics,2025,Molnupiravir,Atrial Fibrillation
38710190,Association of nirmatrelvir-ritonavir with post-acute sequelae and mortality in patients admitted to hospital with COVID-19: a retrospective cohort study.,The Lancet. Infectious diseases,2024,Molnupiravir,Atrial Fibrillation
